Literature DB >> 16759309

Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development.

F Celi1, V Bini, F Papi, E Santilli, M S Castellani, A Ferretti, M Mencacci, M G Berioli, G De Giorgi, A Falorni.   

Abstract

AIM: To determine the influence of Type 1 diabetes mellitus on circulating adipocytokines in children.
METHODS: The circulating concentrations of leptin, adiponectin, resistin and tumour necrosis factor (TNF)-alpha were measured in 91 children, aged 11.1 +/- 2.7 years, with Type 1 diabetes mellitus (T1DM). Ninety-one healthy children were selected as control subjects.
RESULTS: Body mass index-adjusted leptin concentrations were higher in the pubertal diabetic children compared with the control children. There was a significant positive correlation between leptin and daily insulin dose in the diabetic group. Circulating adiponectin concentrations were higher in the prepubertal diabetic children and were positively associated with HbA(1c). Resistin concentrations were lower in the prepubertal non-diabetic subjects compared with the pubertal non-diabetic children, whose values were higher than those of the diabetic children. TNF-alpha concentrations were similar in non-diabetic and diabetic children.
CONCLUSIONS: Circulating concentrations of adipocytokines are abnormal in Type 1 diabetic children, although the direction of change differs by cytokine. Pubertal development, in addition to insulin treatment and glycaemic control, also influences the concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759309     DOI: 10.1111/j.1464-5491.2006.01823.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2012-03-14       Impact factor: 4.406

2.  Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.

Authors:  A Kaas; C Pfleger; L Hansen; K Buschard; N C Schloot; B O Roep; H B Mortensen
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 3.  Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes?

Authors:  Milagros Gloria Huerta
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

4.  Adiponectin and catecholamine concentrations during acute exercise in children with type 1 diabetes.

Authors: 
Journal:  Pediatr Diabetes       Date:  2008-06       Impact factor: 4.866

5.  Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation.

Authors:  Krystallenia I Alexandraki; Christina Piperi; Panayiotis D Ziakas; Nikolaos V Apostolopoulos; Konstantinos Makrilakis; Vassiliki Syriou; Evanthia Diamanti-Kandarakis; Gregory Kaltsas; Anastasios Kalofoutis
Journal:  J Clin Immunol       Date:  2008-01-26       Impact factor: 8.317

6.  The association between adiponectin/leptin ratio and diabetes type: the SEARCH for Diabetes in Youth Study.

Authors:  David M Maahs; Richard F Hamman; Ralph D'Agostino; Lawrence M Dolan; Guiseppina Imperatore; Jean M Lawrence; Santica M Marcovina; Elizabeth J Mayer-Davis; Catherine Pihoker; Dana Dabelea
Journal:  J Pediatr       Date:  2009-07       Impact factor: 4.406

Review 7.  Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes.

Authors:  Hanieh Yaghootkar; Claudia Lamina; Robert A Scott; Zari Dastani; Marie-France Hivert; Liling L Warren; Alena Stancáková; Sarah G Buxbaum; Leo-Pekka Lyytikäinen; Peter Henneman; Ying Wu; Chloe Y Y Cheung; James S Pankow; Anne U Jackson; Stefan Gustafsson; Jing Hua Zhao; Christie M Ballantyne; Weijia Xie; Richard N Bergman; Michael Boehnke; Fatiha el Bouazzaoui; Francis S Collins; Sandra H Dunn; Josee Dupuis; Nita G Forouhi; Christopher Gillson; Andrew T Hattersley; Jaeyoung Hong; Mika Kähönen; Johanna Kuusisto; Lyudmyla Kedenko; Florian Kronenberg; Alessandro Doria; Themistocles L Assimes; Ele Ferrannini; Torben Hansen; Ke Hao; Hans Häring; Joshua W Knowles; Cecilia M Lindgren; John J Nolan; Jussi Paananen; Oluf Pedersen; Thomas Quertermous; Ulf Smith; Terho Lehtimäki; Ching-Ti Liu; Ruth J F Loos; Mark I McCarthy; Andrew D Morris; Ramachandran S Vasan; Tim D Spector; Tanya M Teslovich; Jaakko Tuomilehto; Ko Willems van Dijk; Jorma S Viikari; Na Zhu; Claudia Langenberg; Erik Ingelsson; Robert K Semple; Alan R Sinaiko; Colin N A Palmer; Mark Walker; Karen S L Lam; Bernhard Paulweber; Karen L Mohlke; Cornelia van Duijn; Olli T Raitakari; Aurelian Bidulescu; Nick J Wareham; Markku Laakso; Dawn M Waterworth; Debbie A Lawlor; James B Meigs; J Brent Richards; Timothy M Frayling
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

8.  Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM.

Authors:  Metin Guclu; Ozen Oz Gul; Soner Cander; Oguzkaan Unal; Guven Ozkaya; Emre Sarandol; Canan Ersoy
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

Review 9.  Current trends in the monitoring and treatment of diabetic retinopathy in young adults.

Authors:  Dorota Raczyńska; Katarzyna Zorena; Beata Urban; Dominik Zalewski; Andrzej Skorek; Grażyna Malukiewicz; Bartosz L Sikorski
Journal:  Mediators Inflamm       Date:  2014-02-13       Impact factor: 4.711

10.  Serum adiponectin and hsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus.

Authors:  Damla Gökşen; Ertürk Levent; Sakine Kar; Samim Ozen; Sükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.